Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Treatment of breast cancer in the elderly : a prospective, population-based Swiss study
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 2146016
Author(s) Joerger, M; Thürlimann, B; Savidan, A; Frick, H; Rageth, C; Lütolf, U; Vlastos, G; Bouchardy, C; Konzelmann, I; Bordoni, A; Probst-Hensch, N; Jundt, G; Ess, S
Author(s) at UniBasel Probst Hensch, Nicole
Year 2013
Title Treatment of breast cancer in the elderly : a prospective, population-based Swiss study
Journal Journal of geriatric oncology
Volume 4
Number 1
Pages / Article-Number 39-47
Keywords Breast cancer, Elderly, Radiotherapy, Sentinel lymph node biopsy, Chemotherapy
Abstract Objectives: The primary objective of this population-based study is to describe the patterns of care of elderly patients with breast cancer (BC), and evaluate potential causative factors for the decrease in BC-specific survival (BCSS) in the elderly.Patients and Methods: We included all or representative samples of patients with newly diagnosed BC from seven Swiss cancer-registries between 2003 and 2005 (n=4820). Surgical and non-surgical BC treatment was analyzed over 5 age groups (<65, 65 to <70, 70 to <75, 75 to <80 and >= 80 years), and the predictive impact of patient age on specific treatments was calculated using multivariate logistic regression analysis.Results: The proportion of locally advanced, metastatic and incompletely staged BC increased with age. The odds ratio for performing breast-conserving surgery (BCS) in stages I-II BC (0.37), sentinel lymph node dissection (SLND) in patients with no palpable adenopathy (0.58), post-BCS radiotherapy (0.04) and adjuvant endocrine treatment (0.23) were all in disfavor of patients >= 80 years of age compared to their younger peers. Only 36% of patients >= 80 years of age with no palpable adenopathy underwent SLND. In the adjusted model, higher age was a significant risk factor for omitting post-BCS radiotherapy, SLND and adjuvant endocrine treatment.Conclusions: This study found an increase in incomplete diagnostic assessment, and a substantial underuse of BCS, post-BCS radiotherapy, SLND and adjuvant endocrine treatment in elderly patients with BC. There is a need for improved management of early BC in the elderly even in a system with universal access to health care services. (C) 2012 Elsevier Ltd. All rights reserved.
Publisher Elsevier Science
ISSN/ISBN 1879-4068
edoc-URL http://edoc.unibas.ch/dok/A6174351
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.jgo.2012.08.002
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/24071491
ISI-Number WOS:000314376600006
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.578 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
19/04/2024